New study on non-PIK3CA vascular malformations: 65.9% somatic mosaicism & high gene overlap. Tissue NGS is key! Alpelisib shows promise in TEK cases.

New study on non-PIK3CA vascular malformations: 65.9% somatic mosaicism & high gene overlap. Tissue NGS is key! Alpelisib shows promise in TEK cases.